x-close
  • Media centre
search-button

Contact us & find services

MSI Reproductive Choices
  • Who we are
  • What we do
  • Impact
  • Get involved
  • Latest
Donate

Who we are

We’re 9,000 team members working across 36 countries, all united by our support for reproductive choice.

Read more

  • Our story
  • Global strategy
  • Partners
  • Governance and financial statements
  • Team
  • Diversity, equality & inclusion
  • Careers

What we do

MSI Reproductive Choices provides contraception and abortion services that enable women all over the world to choose their own futures.

Read more

    • All services
    • Abortion care
    • Contraception
    • Broader healthcare
  • Advocacy
  • Where we work
    • Gender equality
    • Adolescent support
    • Leave no one behind 
    • Self-managed health
    • Health system strengthening
    • Humanitarian aid
    • Climate resilience
  • Projects
  • Technical expertise
  • Abortion Rights

Submenu

Text

Read more

000 000 0000

  • Submenu
  • Submenu
  • Submenu

Get involved

Support from people like you will help us to bring reproductive choice to millions of women globally. Choose Choice.

Read more

  • Donate
  • Sign up for emails
  • Share your story 
    • All campaigns 
    • Abortion is healthcare not a crime
    • Choice on the ballot
    • Roe v Wade: Protect Choice
    • Finishing the contraceptive revolution
    • Abortion language guide
  • Philanthropy 
  • Ways to give
  • Leave a legacy

Latest

Access the latest news, views, research and explainers on all things sexual and reproductive health and rights.

Read more

  • News
  • Stories
  • Resources
  • Blogs

Submenu

Text

Read more

000 000 0000

  • Submenu
  • Submenu
  • Submenu
x-close
MSI Reproductive Choices
Donate
search-button
menu-icon
x-close
  • Who we are
  • What we do
  • Impact
  • Get involved
  • Latest
  • Who we are
  • Our Story
  • Global strategy
  • Partners
  • Governance and financial statements
  • Team
  • Diversity, equality & inclusion
  • Careers
  • What we do
    • Services
    • Abortion care
    • Contraception
    • Broader healthcare
  • Advocacy
  • Where we work
  • Projects
    • Gender equality
    • Adolescent support
    • Leave no one behind 
    • Self-managed health
    • Health system strengthening
    • Humanitarian aid
    • Climate resilience
  • Technical expertise
  • Get involved
  • Donate
  • Sign up for emails
  • Share your story
    • All campaigns 
    • Roe v Wade: Protect Choice
    • Let’s decriminalise abortion
    • Stand For Choice
    • Finishing the contraceptive revolution
    • Smash abortion stigma
    • Abortion language guide
  • Philanthropy 
  • Ways to give
  • Leave a legacy
  • Donate
  • Media Centre
  • Contact & find services
  • MSI launches new digital privacy campaign, the Vagina Privacy Network (VPN), on Dobbs v. Jackson anniversary  

    MSI launches new digital privacy campaign, the Vagina Privacy Network (VPN), on Dobbs v. Jackson anniversary  

    WASHINGTON, D.C. / LONDON, June 24, 2024 – MSI Reproductive Choices, a global leader in reproductive health services,​ has today announced the launch of its new digital reproductive healthcare campaign: Vagina Privacy Network (VPN). Created …

    24/06/2024
  • MSI Statement on the Second Anniversary of Dobbs

    MSI Statement on the Second Anniversary of Dobbs

    The Supreme Court of the United States will hear oral arguments around access to mifepristone, an essential abortion medication that is used by more than 5 million people in the US. Read our statement.

    24/06/2024
  • Press Release: Meta and Google restrict access to reproductive health information

    Press Release: Meta and Google restrict access to reproductive health information

    New report: Meta and Google restrict access to reproductive health information in Africa, Asia, and Latin America – while enabling misinformation and abuse.

    27/03/2024
  • MSI Statement on U.S. Supreme Court Hearing on Mifepristone

    MSI Statement on U.S. Supreme Court Hearing on Mifepristone

    The Supreme Court of the United States will hear oral arguments around access to mifepristone, an essential abortion medication that is used by more than 5 million people in the US. Read our statement.

    26/03/2024
  • New Cancun abortion clinic offers greater choice for Mexican women and US residents  

    New Cancun abortion clinic offers greater choice for Mexican women and US residents  

    Fundación MSI, MSI Reproductive Choices’ Mexico program, has opened a new abortion clinic in Cancun, expanding access to Mexican women and offering a lifeline to Americans who have been denied abortion rights since the overturning …

    04/12/2023
  • MSI comment on Court of Appeal ruling on UK abortion case

    MSI comment on Court of Appeal ruling on UK abortion case

    On 12th June 2023, in a rare and distressing case, a woman was sentenced for ending her own pregnancy outside the parameters of the Abortion Act 1967.Today, the Court of Appeal has reduced her sentence to 14 months and ruled it should be suspended, meaning that she will be released from prison. The judge stated…

    18/07/2023
  • MSI comment on woman sentenced for ending her own pregnancy

    MSI comment on woman sentenced for ending her own pregnancy

    MSI comment on woman sentenced for ending her own pregnancy in the UK.

    13/06/2023
  • Davina McCall is right, it’s time to complete the contraception revolution

    Davina McCall is right, it’s time to complete the contraception revolution

    MSI Press Release: As a new Channel 4 documentary presented by Davina McCall raises awareness about contraception in the UK, we can’t forget the 257 million women around the world who have no access.

    08/06/2023
  • MSI Nepal welcomes Norwegian Minister and Ambassador

    MSI Nepal welcomes Norwegian Minister and Ambassador

    MSI Nepal was delighted to welcome the Norwegian International Development Minister, Ms. Anne Beate Tvinnerreim; the Norwegian Ambassador to Nepal, Ms. Torum Dramdal; senior staff and diplomats from the Norwegian Embassy and delegates from the …

    15/05/2023
  • MSI comment on decision to block FDA approval of mifepristone

    MSI comment on decision to block FDA approval of mifepristone

    Last Friday, a US federal judge moved to block the approval of mifepristone, one of two drugs used in more than half of all abortions in the United States. This decision is based on ideology, not evidence. Read our full statement.

    11/04/2023
←Previous Page Next Page→

Who we are

  • Who we are
  • Our story
  • Global strategy
  • Careers

What we do

  • What we do
  • Services
  • Where we work
  • Projects

Impact

  • Impact

Get involved

  • Get involved
  • Donate
  • Sign up for emails
  • Share your story 

More from us

  • Latest
  • Contact us & find services
  • Media centre
  • Tenders
MSI Reproductive Choices

CHOOSE CHOICE


MSI Reproductive Choices

CHOOSE CHOICE

Who we are

  • Our story
  • Global strategy
  • Careers

What we do

  • Services
  • Where we work
  • Projects

Get involved

  • Donate
  • Sign up for emails
  • Share your story 

More from us

  • Tenders
  • Media centre
  • Legal Documents

Latest

Contact us & find services


Follow us

  • X
  • Instagram
  • Facebook
  • LinkedIn
  • YouTube

MSI Reproductive Choices, 1 Conway Street, Fitzroy Square, London, W1T 6LP, UK.
Registered charity in England and Wales, charity number: 265543.

© MSI Reproductive Choices 2025

  • Privacy policy
  • Cookie policy
  • Anti-modern slavery statement